Scientific Sessions 2025  /  Pecha Kucha Says: It’s All About Managing Cardiovascular-Kidney-Metabolic Health  /  The Intersection of Liver and CKM Syndrome
Logo

American Heart Association

  127
  0

Final ID:

The Intersection of Liver and CKM Syndrome

  • Pandey, Ambarish  ( UT Southwestern Medical Center , Dallas , Texas , United States )
  • Sanyal, Arun  ( Virginia Commonwealth University , Glen Allen , Virginia , United States )
  • Mehta, Anurag  ( Virginia Commonwealth University , Glen Allen , Virginia , United States )
  • Mamas, Mamas  ( University of Keele , Keele , United Kingdom )
  • Rajapreyar, Indranee  ( Thomas Jefferson University Hospitals , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Ambarish Pandey: DO have relevant financial relationships ; Consultant:Tricog:Active (exists now) ; Consultant:Sarfez Therapeutics, Edwards Lifesciences, Merck, Bayer, Anumana, Alleviant, Pfizer, Abbott, Axon Therapies, Kilele Health, Acorai, Kardigan, Novartis, Idorsia Pharma, and Science37:Active (exists now) ; Consultant:Rivus:Active (exists now) ; Consultant:iRhythm:Active (exists now) ; Researcher:SQ innovations:Active (exists now) ; Research Funding (PI or named investigator):SC Pharma:Active (exists now) ; Consultant:Astra Zeneca:Active (exists now) ; Research Funding (PI or named investigator):Ultromics:Active (exists now) ; Research Funding (PI or named investigator):Roche:Active (exists now) ; Consultant:Ultromics:Active (exists now) ; Consultant:Roche:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) | Arun Sanyal: DO have relevant financial relationships ; Consultant:Eli Lilly, Echosens, Abbott:Active (exists now) ; Individual Stocks/Stock Options:Durect, Genfit, Tiziana, Inversago:Active (exists now) ; Royalties/Patent Beneficiary:Elsevier and UpToDate:Active (exists now) ; Other (please indicate in the box next to the company name):Institution has received Grant support from:Merck, Ocelot, Novartis, Salix:Active (exists now) ; Other (please indicate in the box next to the company name):Institution has received Grant support from: Gilead, Intercept, Mallinckrodt:Active (exists now) ; Other (please indicate in the box next to the company name):Institution has received Grant support from:Astra Zeneca, Bristol Myers Squibb:Active (exists now) ; Consultant:Takesa, Surrozen, Terns, Zydus:Active (exists now) ; Consultant:Salix, Myovent, Media Technologies, Sequana:Active (exists now) ; Consultant:Akero, Novo Nordisk, Path AI, Pfizer, Poxel:Active (exists now) ; Consultant:Lipocine, Madrigal, Merck, Glaxo Smith Kline, Novartis:Active (exists now) ; Consultant:Genetech, Gilead, Histoindex, Janssen:Active (exists now) ; Consultant:Boehringer Ingleheim, Bristol Myers Squibb:Active (exists now) ; Consultant:Astra Zeneca, Alnylam, Regeneron:Active (exists now) ; Consultant:Variant, Cascade, 89 Bio:Active (exists now) ; Consultant:Corcept, Arrowhead, Boston Pharmaceuticals:Active (exists now) ; Consultant:Promed, Genfit, Satellite Bio:Active (exists now) | Anurag Mehta: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen:Active (exists now) ; Research Funding (PI or named investigator):Novartis:Active (exists now) | Mamas Mamas: DO NOT have relevant financial relationships | Indranee Rajapreyar: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Pecha Kucha Says: It’s All About Managing Cardiovascular-Kidney-Metabolic Health

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Cardiovascular Seminar

More abstracts on this topic:
The Elephant in the Room: Addressing Excess and Dysfunctional Adiposity

Neeland Ian, Testani Jeffrey, Ndumele Chiadi

It’s Complicated: Managing Multi-Organ Dysfunction

Eisen Howard, Pagidipati Neha, Kohut Andrew

More abstracts from these authors:
Heart and hepatic health: the interconnectedness of cardiac and liver health

Sanyal Arun, Loomba Rohit, Vanwagner Lisa, Rao Vishal

Lipoprotein(a): Modifiable Risk Factor, Update in Targeted Therapies

Yeang Calvin, Bhatia Harpreet, Mehta Anurag

You have to be authorized to contact abstract author. Please, Login
Not Available